Clinical Translational Core
Clinical Translational Core
批准号:
8659014
负责人:
Sally Ozonoff
金额:
$18.89万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-24 至 2018-06-30
关键词:
AddressAgeBehavioralBudgetsCharacteristicsChildClinicalCommunitiesCommunity OutreachDevelopmentDiagnosisDiagnosticDown SyndromeEconomicsEligibility DeterminationEnrollmentEthnic OriginEvaluationExclusion CriteriaFragile X SyndromeFundingGeneral PopulationGrantHumanHuman ResourcesIndividualInstitutesLow PrevalenceMental Retardation and Developmental Disabilities Research CentersMonitorParentsParticipantPopulationProcessProductivityRaceRecruitment ActivityRegistriesResearchResearch InfrastructureResearch PersonnelResourcesSamplingScienceServicesSystemTrainingbiobehaviorcostcost effectivenessdesignexperienceimprovedinclusion criteriaintellectual and developmental disabilitymeetingsneuroimagingorganizational structurestandardize measure
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Clinical Translational (CT) Core addresses the challenges facing investigators who conduct human
behavioral and biobehavioral research on IDD conditions, such as autism, fragile X syndrome, and Down
syndrome. Participants can be difficult to recruit because of their relatively low prevalence in the general
population. Moreover, once recruited, these participants require evaluations by professionals with specialized
training to confirm diagnoses and determine whether inclusion/exclusion criteria are met. Recruitment of
typically developing control participants can also be challenging, particularly for studies of young children that
require biologic sampling or neuroimaging because parents are often reluctant to enroll. The CT Core is
designed to help IDDRC investigators overcome these challenges by providing services that include participant
recruitment, community outreach, initial diagnostic qualification, assessment of inclusion and exclusion criteria,
and allocation of personnel and resources for these activities. The CT Core staff and resources dedicated to
these activities will significantly diversify the available pool of participants; improve cost effectiveness
efficiency, and productivity by sharing participant qualification characteristics across projects; and provide
resources that are beyond the expertise or budget of specific investigators but are essential to the highest
quality behavioral and biobehavioral science. The individuals and infrastructure associated with the proposed
CT Core have provided similar services to many funded studies at the MIND Institute over the last dozen
years, although these services were more limited in scope and were not previously integrated into a single
organizational structure. The integration proposed and the expansion afforded by the support of the
IDDRC U54 grant (and the additional institutional support of the MIND Institute and UC Davis) will
increase efficiency, lower costs of services thereby encouraging greater use by IDDRC investigators,
expand diagnostic evaluation services, and increase recruitment efforts, especially as regards the
recruitment of ethnically, racially, and economically diverse participants.
The primary objective of the CT Core is to establish and maintain an operational framework that is optimal
for recruitment and diagnostic assessment and characterization of a diverse range of special and typical
populations. We will achieve this objective by addressing the following Specific Aims:
1. Enhance recruitment of a diverse range of participants through a systematic process of community
engagement, including multiple ethnicities, races, and economic backgrounds with both atypical and typical
development across a wide age span.
2. Maintain a participant registry and tracking system that includes critical descriptive information,
permitting investigators to select participants for recruitment who are most likely to meet specific eligibility
criteria.
3. Provide experienced evaluators who can advise studies in best practices for diagnostic assessment and
standardized measure selection, provide training in administration of standardized measures, establish initial
reliability and ongoing monitoring of administration fidelity, and conduct specialized diagnostic assessments as
needed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Addressing disparities in ASD diagnosis using a direct-to-home telemedicine tool: Evaluation of diagnostic accuracy, psychometric properties, and family engagement
-
批准号:10277413
-
项目类别:
-
资助金额:$77.79万
-
财政年份:2021
-
负责人:Sally Ozonoff
-
依托单位:
Addressing disparities in ASD diagnosis using a direct-to-home telemedicine tool: Evaluation of diagnostic accuracy, psychometric properties, and family engagement
-
批准号:10461849
-
项目类别:
-
资助金额:$70.64万
-
财政年份:2021
-
负责人:Sally Ozonoff
-
依托单位:
Addressing disparities in ASD diagnosis using a direct-to-home telemedicine tool: Evaluation of diagnostic accuracy, psychometric properties, and family engagement
-
批准号:10667589
-
项目类别:
-
资助金额:$66.92万
-
财政年份:2021
-
负责人:Sally Ozonoff
-
依托单位:
Core B. Clinical Translational Core
-
批准号:10220102
-
项目类别:
-
资助金额:$32.45万
-
财政年份:2020
-
负责人:Sally Ozonoff
-
依托单位:
Core B. Clinical Translational Core
-
批准号:10682398
-
项目类别:
-
资助金额:$32.45万
-
财政年份:2020
-
负责人:Sally Ozonoff
-
依托单位:
Core B. Clinical Translational Core
-
批准号:10430107
-
项目类别:
-
资助金额:$32.45万
-
财政年份:2020
-
负责人:Sally Ozonoff
-
依托单位:
Novel video-based approaches for detection of autism risk in the first year of life
-
批准号:10434011
-
项目类别:
-
资助金额:$71.75万
-
财政年份:2019
-
负责人:Sally Ozonoff
-
依托单位:
Novel video-based approaches for detection of autism risk in the first year of life
-
批准号:10794112
-
项目类别:
-
资助金额:$15.85万
-
财政年份:2019
-
负责人:Sally Ozonoff
-
依托单位:
Novel video-based approaches for detection of autism risk in the first year of life
-
批准号:10011854
-
项目类别:
-
资助金额:$71.09万
-
财政年份:2019
-
负责人:Sally Ozonoff
-
依托单位:
Novel video-based approaches for detection of autism risk in the first year of life
-
批准号:10656438
-
项目类别:
-
资助金额:$61.15万
-
财政年份:2019
-
负责人:Sally Ozonoff
-
依托单位:
Novel video-based approaches for detection of autism risk in the first year of life
-
批准号:10201443
-
项目类别:
-
资助金额:$71.75万
-
财政年份:2019
-
负责人:Sally Ozonoff
-
依托单位:
Longitudinal Investigation of Social-Communication and Attention Processes in School-Aged Children at Genetic Risk for Autism
-
批准号:9238089
-
项目类别:
-
资助金额:$72.32万
-
财政年份:2016
-
负责人:Sally Ozonoff
-
依托单位:
Longitudinal Investigation of Social-Communication and Attention Processes in School-Aged Children at Genetic Risk for Autism
-
批准号:9349602
-
项目类别:
-
资助金额:$60.75万
-
财政年份:2016
-
负责人:Sally Ozonoff
-
依托单位:
Development of a Prospective Video-Based Measure to Identify ASD Risk in Infancy
-
批准号:8902954
-
项目类别:
-
资助金额:$46.55万
-
财政年份:2013
-
负责人:Sally Ozonoff
-
依托单位:
Development of a Prospective Video-Based Measure to Identify ASD Risk in Infancy
-
批准号:8577930
-
项目类别:
-
资助金额:$57.62万
-
财政年份:2013
-
负责人:Sally Ozonoff
-
依托单位:
Development of a Prospective Video-Based Measure to Identify ASD Risk in Infancy
-
批准号:8712556
-
项目类别:
-
资助金额:$47.8万
-
财政年份:2013
-
负责人:Sally Ozonoff
-
依托单位:
Infants at Risk of Autism: A Longitudinal Study
-
批准号:7752471
-
项目类别:
-
资助金额:$59.96万
-
财政年份:2009
-
负责人:Sally Ozonoff
-
依托单位:
Infants at Risk of Autism: A Longitudinal Study
-
批准号:7988586
-
项目类别:
-
资助金额:$58.26万
-
财政年份:2009
-
负责人:Sally Ozonoff
-
依托单位:
Infants at Risk of Autism: A Longitudinal Study
-
批准号:7580369
-
项目类别:
-
资助金额:$58.38万
-
财政年份:2009
-
负责人:Sally Ozonoff
-
依托单位:
Infants at Risk of Autism: A Longitudinal Study
-
批准号:8196835
-
项目类别:
-
资助金额:$58.72万
-
财政年份:2009
-
负责人:Sally Ozonoff
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: